Found: 29 resources
Assessment of cytogenetic response after treatment with imatinib mesylate in patients with chronic phase chronic myeloid leukemia
Iraqi Journal of Hematology, 2014, Volume 3, Issue 1, Pages 56-61
Changes of immunological, Cytogenetic & Hematological Profiles in Chronic Myeloid Leukemia Treated with Imatinib Mesylate
Iraqi Journal of Hematology, 2014, Volume 3, Issue 1, Pages 35-42
LTB4R Gene Expression in Chronic Myeloid Leukemia in Iraq
Iraqi Journal of Science, 2023, Volume 64, Issue 5, Pages 2202-2214
Hematological events and thyroid status in Imatinib treated CML Iraqi
Iraqi Journal of Cancer and Medical Genetics, 2016, Volume 9, Issue 2, Pages 133-137
Survival of Patients with CML on Imatinib Experience with 44 IraqiPatients
Journal of the Faculty of Medicine Baghdad, 2008, Volume 50, Issue 3, Pages 286-295
Molecular assessment of apoptotic genes in leukemic patients
Journal Of Wassit For Science & Medicine, 2015, Volume 8, Issue 1, Pages 105-114
Influence of multi-drug transporter gene ABCG2 polymorphism (C421A) in clinical out care in some Iraqi chronic myeloid leukemia patients treated with imatinib mesylate
Iraqi Journal of Biotechnology, 2017, Volume 16, Issue 3, Pages 98-107
Association of T315I mutation with resistance to tyrosine kinaseinhibitor therapy in patients with CML attended theOncology-Hematology center in Al-Najaf city of Iraq
Karbala International Journal of Modern Science, 2017, Volume 3, Issue 4, Pages 231-240
Glutathione S-Transferase Mu 1 and Glutathione S-transferase theta 1 Genes Polymorphism and Susceptibility to Chronic Myeloid Leukemia in Erbil-Iraq Kurdistan Region
Zanco Journal of Pure and Applied Sciences, 2020, Volume 32, Issue 6, Pages 54-59
The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients
Al-Mustansiriyah Journal of Science, 2023, Volume 34, Issue 1, Pages 16-22